ASTARPRD
NATi is seeking a Scientist with strong pharmacology expertise to support oligonucleotide discovery programs focused on obesity and metabolic dysfunction-associated steatohepatitis (MASH). The role involves independently designing, executing, and analyzing integrated in vitro and in vivo pharmacology studies to generate decision-enabling data. This position is ideal for candidates with a BSc/MSc and 10-12 years of experience, or a PhD with 7 years of experience, who can work with minimal supervision.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ASTARPRD.
ASTARPRD didn’t post a salary, so this is our estimate from similar listings.
19% below the average for this role
Senior Scientist, In Vivo Metabolism Bioscience
AstraZeneca
Associate Scientist
Medicilon Inc
Scientist IV Pharmacology Contractor
Qpex Biopharma
Principal Scientist – Cardiometabolic Diseases/Obesity Research
Amgen
Scientist IV Pharmacology
Qpex Biopharma
Director of In Vivo Pharmacology
Flagship Pioneering, Inc.